This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- South San Francisco, CA (US) (2018 - 2021)
- San Francisco, CA (US) (2019 - 2022)
Company Filing History:
Years Active: 2018-2022
Title: Mary Keir: Innovator in Gastrointestinal Health
Introduction
Mary Keir is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of gastrointestinal health, particularly in the diagnosis and treatment of inflammatory bowel diseases. With a total of 5 patents to her name, her work has the potential to impact many lives.
Latest Patents
Mary's latest patents focus on methods for diagnosing and treating inflammatory bowel disease. These patents include biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies. The methods provided in her patents aim to treat gastrointestinal inflammatory disorders such as ulcerative colitis and Crohn's disease. Additionally, her work emphasizes the use of predictive biomarkers for the treatment of these inflammatory bowel diseases.
Career Highlights
Mary Keir is currently associated with Genentech, Inc., where she continues to innovate in her field. Her expertise and dedication have led to advancements that could change the landscape of treatment for gastrointestinal disorders.
Collaborations
Some of her notable coworkers include Gaik Wei Tew and Jason A Hackney. Their collaborative efforts contribute to the ongoing research and development in the area of inflammatory bowel diseases.
Conclusion
Mary Keir's work exemplifies the spirit of innovation in the medical field. Her contributions to the diagnosis and treatment of inflammatory bowel diseases are invaluable and highlight the importance of research in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile